Michael W Varner
Physician in Salt Lake City, UT

License number
Utah 176815-1205
Issued Date
Jun 17, 1987
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician & Surgeon
Address
Address
Salt Lake City, UT

Personal information

See more information about Michael W Varner at radaris.com
Name
Address
Phone
Michael Varner, age 75
1444 E Tomahawk Dr, Salt Lake Cty, UT 84103
Michael Varner, age 75
1444 Tomahawk Dr, Salt Lake Cty, UT 84103
(801) 635-5472
Michael O Varner
2870 3900 S, Salt Lake City, UT 84124

Professional information

See more information about Michael W Varner at trustoria.com
Michael Varner Photo 1
Method And Apparatus For Predicting Material Hypertension During Pregnancy Using Coherence Analysis Of Material And Fetal Blood Velocity Waveforms

Method And Apparatus For Predicting Material Hypertension During Pregnancy Using Coherence Analysis Of Material And Fetal Blood Velocity Waveforms

US Patent:
7374539, May 20, 2008
Filed:
Sep 2, 2004
Appl. No.:
10/934656
Inventors:
Kumari L. Fernando - Salt Lake City UT, US
V. John Mathews - Salt Lake City UT, US
Edward B. Clark - Salt Lake City UT, US
Michael W. Varner - Salt Lake City UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61B 8/00
US Classification:
600454, 600481
Abstract:
An embodiment of a method of predicting maternal hypertension during pregnancy is disclosed. The method may include measuring a maternal blood velocity waveform and measuring a fetal blood velocity waveform. The method may further include the calculation of a coherence value using a magnitude-squared coherence function between the maternal and fetal blood velocity waveforms and comparing the coherence value to a predetermined threshold value.


Michael Varner Photo 2
Michael Varner, Salt Lake City UT

Michael Varner, Salt Lake City UT

Work:
University Hospital
50 N Medical Dr, Salt Lake City, UT 84132 Mc Kay Dee Neonatology
4401 Harrison Blvd, Ogden, UT 84403 University of Utah School of Medicine
30 N 1900 E, Salt Lake City, UT 84132 School of Medicine
30 N Medical Dr, Salt Lake City, UT 84132 Ihc Dixie Maternal Fetal Med
544 S 400 E, Saint George, UT 84770 Pocatello Women's Health Clnc
777 Hospital Way, Pocatello, ID 83201 St Johns Medical Center
PO Box 428, Jackson, WY 83001


Michael W Varner Photo 3
Dr. Michael W Varner, Murray UT - MD (Doctor of Medicine)

Dr. Michael W Varner, Murray UT - MD (Doctor of Medicine)

Specialties:
Maternal-Fetal Medicine
Address:
Intermountain Medical Center
5121 S Cottonwood St SUITE D100, Murray 84107
(801) 507-7400 (Phone)
University Of Utah OB/GYN
50 N Medical Dr SUITE 2B200, Salt Lake City 84132
(801) 581-7647 (Phone)
5121 S Cottonwood St SUITE 100, Salt Lake City 84107
(801) 507-7400 (Phone)
Certifications:
Fetal Medicine & Maternal Medicine, 2010, Obstetrics & Gynecology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Intermountain Medical Center
5121 S Cottonwood St SUITE D100, Murray 84107
University Of Utah OB/GYN
50 N Medical Dr SUITE 2B200, Salt Lake City 84132
5121 S Cottonwood St SUITE 100, Salt Lake City 84107
Dixie Regional Medical Center
1380 East Medical Center Dr, Saint George 84790
Intermountain Medical Center
5121 Cottonwood St, Murray 84107
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
Education:
Medical School
University Of Minnesota Medical School
University Ia
Graduated: 1979
Graduated: 1981


Michael Varner Photo 4
Compositions And Methods For Diagnosing And Preventing Spontaneous Preterm Birth

Compositions And Methods For Diagnosing And Preventing Spontaneous Preterm Birth

US Patent:
2012004, Feb 23, 2012
Filed:
Feb 24, 2010
Appl. No.:
13/203684
Inventors:
Tracy Ann Manuck - Salt Lake City UT, US
Michael W. Varner - Salt Lake City UT, US
Assignee:
UNIVERSITY OF UTAH RESEARCH FOUNDATION - Salt Lake City UT
International Classification:
A61K 31/57, C40B 20/08, A61P 15/06, C40B 40/06
US Classification:
514178, 506 16, 506 6, 514177
Abstract:
Disclosed herein are compositions and methods of identifying a subject at risk for preterm birth and selecting effective therapies for preventing preterm birth in the subject. The disclosed methods generally involve determining the identity of one or more nucleotides in the progesterone receptor (PR) gene of the subject.